Jennifer M Frost

This inventor holds 35 USPTO granted patents and 28 published patent applications and 23 EPO patents, primarily in Cannabinoid Receptor Ligands. Top assignees: Abbvie Inc., Abbott Laboratories Corporation, Calico Life Sciences LLC. Active years: 2008-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer M Frost. Retrieved from https://idiyas.com/inventor/jennifer-m-frost

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 (Patent Applications = 28)

% Patents Active = 34.3

EPO Patents = 23 (Patent Applications = 34)

Average Co-Inventor Count = 6.5

ph-index = 9

Forward Citations = 114(Granted Patents)

Location History:

Grayslake, IL (US) (2008 - 2015)
Gurnee, IL (US) (2012 - 2024)

Company Filing History:

Abbott Laboratories Corporation

patents

2 out of 6

Calico Life Sciences LLC

patents

where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...

Areas of Expertise:

Cannabinoid Receptor Ligands

Protein Tyrosine Phosphatase Inhibitors

Integrated Stress Pathway

Prodrug Modulators

Indazole Ureas

Diazabicyclic Agents

Tricyclic Derivatives

Nicotinic Acetylcholine Receptors

CNS Active Agents

Indoles

Pharmacology

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11939320 - Modulators of the integrated stress pathway (2024-03-26),

2. 11149043 - Prodrug modulators of the integrated stress pathway (2021-10-19),

3. 10954202 - Protein tyrosine phosphatase inhibitors and methods of use thereof (2021-03-23),

4. 10913727 - Modulators of the integrated stress pathway (2021-02-09),

5. 10864196 - Modulators of the integrated stress pathway (2020-12-15),

6. 10851073 - Protein tyrosine phosphatase inhibitors and methods of use thereof (2020-12-01),

7. 10836725 - Modulators of the integrated stress pathway (2020-11-17),

8. 9783527 - Indazole ureas and method of use (2017-10-10),

9. 9682985 - (Indazol-4-yl) hexahydropyrrolopyrrolones and methods of use (2017-06-20),

10. 9193713 - Compounds as cannabinoid receptor ligands (2015-11-24),

11. 9006275 - Compounds as cannabinoid receptor ligands and uses thereof (2015-04-14),

12. 8895592 - Compounds as cannabinoid receptor ligands (2014-11-25),

13. 8865753 - Compounds as cannabinoid receptor ligands (2014-10-21),

14. 8859596 - Compounds as cannabinoid receptor ligands (2014-10-14),

15. 8846730 - Compounds as cannabinoid receptor ligands (2014-09-30),

Title: Innovations and Contributions of Jennifer M Frost in Integrated Stress Response Modulation

Introduction

Jennifer M Frost is a prominent inventor based in Gurnee, Illinois. With an impressive portfolio of 35 patents, she has significantly contributed to the field of integrated stress response modulation, which plays a crucial role in understanding and treating various diseases and conditions.

Latest Patents

Among her latest inventions, Jennifer has developed two noteworthy patents focused on compounds and methods for modulating the integrated stress pathway. The first patent, titled "Modulators of the Integrated Stress Pathway," provides innovative compounds and compositions that are instrumental in the modulation of the integrated stress response (ISR) to treat applicable disorders. The second patent, "Prodrug Modulators of the Integrated Stress Pathway," further explores similar themes, offering methods to effectively manipulate the ISR for therapeutic purposes.

Career Highlights

Jennifer's career is highlighted by her tenures at renowned companies such as AbbVie Inc. and Abbott Laboratories Corporation. Her work at these institutions has allowed her to collaborate on groundbreaking research and innovations in the pharmaceutical sector, particularly in stress response pathways.

Collaborations

Throughout her career, Jennifer has worked alongside esteemed colleagues, including Michael J Dart and William A Carroll. These collaborations have been pivotal in advancing her research and development efforts in the area of integrated stress response modulation.

Conclusion

Jennifer M Frost’s innovative work and numerous patents underscore her integral role in advancing the science of disease treatment through the modulation of the integrated stress pathway. Her contributions continue to influence the pharmaceutical industry and provide hope for addressing complex medical conditions.

Profile summary based on public USPTO records.